Home > Healthcare > Pharmaceuticals > Finished Drug Form > Acitretin Market

Acitretin Market Trends

  • Report ID: GMI9236
  • Published Date: Apr 2024
  • Report Format: PDF

Acitretin Market Trends

Advancements in the treatment of psoriasis have transformed the landscape of dermatological care offering patients with this chronic skin condition a wider array of effective therapeutic options. Among these treatments, acitretin has emerged as a cornerstone medication providing notable benefits in managing moderate to severe cases of psoriasis. With a focus on enhancing efficacy, improving safety profiles, and optimizing patient outcomes, advancements in acitretin therapy have reshaped the way healthcare professionals approach psoriasis treatment.
 

  • Continued research and clinical trials have provided evidence of the efficacy of acitretin in controlling psoriatic symptoms, particularly in cases of moderate to severe psoriasis. Acitretin has been shown to effectively reduce inflammation, normalize skin cell growth, and alleviate symptoms such as redness, scaling, and thickness of lesions.
     
  • Advancements in understanding the genetic and immunological factors contributing to psoriasis have led to the development of personalized treatment approaches. Tailoring acitretin therapy based on individual patient characteristics can optimize treatment outcomes.
     
  • Additionally, acitretin is often used in combination with other psoriasis treatments  such as topical corticosteroids, phototherapy, or biologic agents to enhance efficacy and reduce the dosage required, thereby minimizing side effects. Thus, escalating the growth of the market.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Acitretin market size was USD 33.8 million in 2023 and will register a 4.6% CAGR from 2024 to 2032, attributed to increasing healthcare expenditure, rising incidence of dermatological disorders, along with advancements in medical research and technology.

Demand for acitretin across hospital pharmacies recorded USD 21.7 million by 2032 due to pivotal role of hospitals in treating severe dermatological conditions like psoriasis, where acitretin is a crucial therapeutic option and their centralized distribution network.

North America acitretin industry size will record 4.4% CAGR up to 2032, driven by high prevalence rates of psoriasis and other dermatological conditions, robust healthcare infrastructure, and substantial investments in research and development.

Prominent companies including Amneal Pharmaceuticals, Inc., Biophore., Chongqing Huapont Pharmaceutical Co., Ltd., Globe International Limited, GSK Plc, Merck KGaA, Prasco Laboratories, SGPharma Pvt Ltd, Sionc Pharmaceuticals Pvt. Ltd., and Sun Pharma Industries Limited, are operating in the acitretin industry.

Acitretin Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 286
  • Countries covered: 23
  • Pages: 230
 Download Free Sample